MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy

Methotrexate (MTX) is an important component in the therapy used to treat childhood acute lymphoblastic leukemia (ALL). Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme for MTX pharmacokinetics. Two single-nucleotide polymorphisms in MTHFR gene, C677T and A1298C, affecting MTHFR activity,...

Descripción completa

Detalles Bibliográficos
Autores principales: Umerez, Maitane, Gutierrez-Camino, Ángela, Muñoz-Maldonado, Carmen, Martin-Guerrero, Idoia, Garcia-Orad, Africa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376125/
https://www.ncbi.nlm.nih.gov/pubmed/28392709
http://dx.doi.org/10.2147/PGPM.S107047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376125/
https://www.ncbi.nlm.nih.gov/pubmed/28392709
http://dx.doi.org/10.2147/PGPM.S107047

Ejemplares similares